Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis

P. Carmeliet, N. Mackman, S. Wyns, Elliot Rosen, L. Kieckens, T. Luther, T. Edgington, D. Collen

Research output: Contribution to journalArticle

Abstract

Tissue factor (TF) of blood coagulation plays a pivotal role in mediating cellular initiation of blood coagulation, by activating factor VII to factor Vila. A role of TF in hemostasis and thrombogenesis following vascular injury or inflammation is suggested by (he induction of TF expression in endothelial cells and in cells of the monocyte lineage, following activation by proinflammatory cytokines or growth factors. TF might, however, also participate in other biological processes including embryogenesis, tumorigenesis, sepsis, atherosclerosis, brain function and kidney disease. The exact in vivo role of TF, and its requirement for interaction with factor VII, in these processes remains, however, to be furhter defined. In order to examine the role of TF in vivo, the rnurine TF gene was disrupted by targeted replacement of the TF promoter, the first exon and part of the second exon by the neoR gene. Genolyping of 350 offspring from heterozygous TF deficient (TF+/- ) breeding pairs resulted in one viable homozygous TF deficient (TF-/-) offspring that survived a few hours after birth. TF-/- embryos generally died in utero around 10.5 days post coitum (dpc) as a result of defective extraembryonic vessel development. Most notably, the large collecting vessels that connect the yolk sac with the embryo were present in 73/100 (73%) TF+/+ yolk sac sections but in 0/54 (0%) TF-/- yolk sac sections (p+/+). The presence of the TF mRNA and protein in the visceral endoderm cells of the yolk sac was identified by RTPCR, immunostaining and procoagulant assay. No factor VIIimmunoreactivity was observed in the yolk sac or embryo at 9.5 dpc, and

Original languageEnglish (US)
Pages (from-to)20
Number of pages1
JournalFibrinolysis
Volume10
Issue numberSUPPL. 3
StatePublished - 1996
Externally publishedYes

Fingerprint

Thromboplastin
Genes
Yolk Sac
Factor VII
Embryonic Structures
Exons
Biological Phenomena
Endoderm
Vascular System Injuries
Kidney Diseases
Brain Diseases
Blood Coagulation
Cell Lineage
Hemostasis
Embryonic Development
Breeding

ASJC Scopus subject areas

  • Hematology

Cite this

Carmeliet, P., Mackman, N., Wyns, S., Rosen, E., Kieckens, L., Luther, T., ... Collen, D. (1996). Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis. Fibrinolysis, 10(SUPPL. 3), 20.

Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis. / Carmeliet, P.; Mackman, N.; Wyns, S.; Rosen, Elliot; Kieckens, L.; Luther, T.; Edgington, T.; Collen, D.

In: Fibrinolysis, Vol. 10, No. SUPPL. 3, 1996, p. 20.

Research output: Contribution to journalArticle

Carmeliet, P, Mackman, N, Wyns, S, Rosen, E, Kieckens, L, Luther, T, Edgington, T & Collen, D 1996, 'Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis', Fibrinolysis, vol. 10, no. SUPPL. 3, pp. 20.
Carmeliet P, Mackman N, Wyns S, Rosen E, Kieckens L, Luther T et al. Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis. Fibrinolysis. 1996;10(SUPPL. 3):20.
Carmeliet, P. ; Mackman, N. ; Wyns, S. ; Rosen, Elliot ; Kieckens, L. ; Luther, T. ; Edgington, T. ; Collen, D. / Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis. In: Fibrinolysis. 1996 ; Vol. 10, No. SUPPL. 3. pp. 20.
@article{3a88ceb601ab4694bf5c0dbe1739b4b2,
title = "Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis",
abstract = "Tissue factor (TF) of blood coagulation plays a pivotal role in mediating cellular initiation of blood coagulation, by activating factor VII to factor Vila. A role of TF in hemostasis and thrombogenesis following vascular injury or inflammation is suggested by (he induction of TF expression in endothelial cells and in cells of the monocyte lineage, following activation by proinflammatory cytokines or growth factors. TF might, however, also participate in other biological processes including embryogenesis, tumorigenesis, sepsis, atherosclerosis, brain function and kidney disease. The exact in vivo role of TF, and its requirement for interaction with factor VII, in these processes remains, however, to be furhter defined. In order to examine the role of TF in vivo, the rnurine TF gene was disrupted by targeted replacement of the TF promoter, the first exon and part of the second exon by the neoR gene. Genolyping of 350 offspring from heterozygous TF deficient (TF+/- ) breeding pairs resulted in one viable homozygous TF deficient (TF-/-) offspring that survived a few hours after birth. TF-/- embryos generally died in utero around 10.5 days post coitum (dpc) as a result of defective extraembryonic vessel development. Most notably, the large collecting vessels that connect the yolk sac with the embryo were present in 73/100 (73{\%}) TF+/+ yolk sac sections but in 0/54 (0{\%}) TF-/- yolk sac sections (p+/+). The presence of the TF mRNA and protein in the visceral endoderm cells of the yolk sac was identified by RTPCR, immunostaining and procoagulant assay. No factor VIIimmunoreactivity was observed in the yolk sac or embryo at 9.5 dpc, and",
author = "P. Carmeliet and N. Mackman and S. Wyns and Elliot Rosen and L. Kieckens and T. Luther and T. Edgington and D. Collen",
year = "1996",
language = "English (US)",
volume = "10",
pages = "20",
journal = "Fibrinolysis",
issn = "0268-9499",
publisher = "Churchill Livingstone",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis

AU - Carmeliet, P.

AU - Mackman, N.

AU - Wyns, S.

AU - Rosen, Elliot

AU - Kieckens, L.

AU - Luther, T.

AU - Edgington, T.

AU - Collen, D.

PY - 1996

Y1 - 1996

N2 - Tissue factor (TF) of blood coagulation plays a pivotal role in mediating cellular initiation of blood coagulation, by activating factor VII to factor Vila. A role of TF in hemostasis and thrombogenesis following vascular injury or inflammation is suggested by (he induction of TF expression in endothelial cells and in cells of the monocyte lineage, following activation by proinflammatory cytokines or growth factors. TF might, however, also participate in other biological processes including embryogenesis, tumorigenesis, sepsis, atherosclerosis, brain function and kidney disease. The exact in vivo role of TF, and its requirement for interaction with factor VII, in these processes remains, however, to be furhter defined. In order to examine the role of TF in vivo, the rnurine TF gene was disrupted by targeted replacement of the TF promoter, the first exon and part of the second exon by the neoR gene. Genolyping of 350 offspring from heterozygous TF deficient (TF+/- ) breeding pairs resulted in one viable homozygous TF deficient (TF-/-) offspring that survived a few hours after birth. TF-/- embryos generally died in utero around 10.5 days post coitum (dpc) as a result of defective extraembryonic vessel development. Most notably, the large collecting vessels that connect the yolk sac with the embryo were present in 73/100 (73%) TF+/+ yolk sac sections but in 0/54 (0%) TF-/- yolk sac sections (p+/+). The presence of the TF mRNA and protein in the visceral endoderm cells of the yolk sac was identified by RTPCR, immunostaining and procoagulant assay. No factor VIIimmunoreactivity was observed in the yolk sac or embryo at 9.5 dpc, and

AB - Tissue factor (TF) of blood coagulation plays a pivotal role in mediating cellular initiation of blood coagulation, by activating factor VII to factor Vila. A role of TF in hemostasis and thrombogenesis following vascular injury or inflammation is suggested by (he induction of TF expression in endothelial cells and in cells of the monocyte lineage, following activation by proinflammatory cytokines or growth factors. TF might, however, also participate in other biological processes including embryogenesis, tumorigenesis, sepsis, atherosclerosis, brain function and kidney disease. The exact in vivo role of TF, and its requirement for interaction with factor VII, in these processes remains, however, to be furhter defined. In order to examine the role of TF in vivo, the rnurine TF gene was disrupted by targeted replacement of the TF promoter, the first exon and part of the second exon by the neoR gene. Genolyping of 350 offspring from heterozygous TF deficient (TF+/- ) breeding pairs resulted in one viable homozygous TF deficient (TF-/-) offspring that survived a few hours after birth. TF-/- embryos generally died in utero around 10.5 days post coitum (dpc) as a result of defective extraembryonic vessel development. Most notably, the large collecting vessels that connect the yolk sac with the embryo were present in 73/100 (73%) TF+/+ yolk sac sections but in 0/54 (0%) TF-/- yolk sac sections (p+/+). The presence of the TF mRNA and protein in the visceral endoderm cells of the yolk sac was identified by RTPCR, immunostaining and procoagulant assay. No factor VIIimmunoreactivity was observed in the yolk sac or embryo at 9.5 dpc, and

UR - http://www.scopus.com/inward/record.url?scp=33846691973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846691973&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 20

JO - Fibrinolysis

JF - Fibrinolysis

SN - 0268-9499

IS - SUPPL. 3

ER -